BOCA RATON, FL -- (MARKET WIRE) -- March 13, 2007 -- Alliant Diagnostics, Inc. (PINKSHEETS: ALNA), a rapidly growing national provider of background and drug screening services, announced today that fiscal year ended December 31, 2006 revenues on an unaudited basis were approximately $3,390,496.93 up from $2,956,923.36 reported for year ended December 31, 2005 with a net operating loss of approximately $496,669.29 compared to a net operating loss of $149,816 in fiscal year ended December 31, 2005.
